Small listed hospital operator TMC Life Sciences is paying $111m for a 1.6 hectare development site in Malaysia, 40km from Singapore. The site in Johor Baru, Malayasia’s third largest city, has planning approval for a large medical hub. It is being bought from a company owned by businessman Peter Lim who also has a majority of TMC Life Sciences. The site is also 30% owned by the Crown prince of Johor, Tunku Ismail Idris. Healthcare Nova speaks to Dr. Wong Chiang Yin, executive director at TMC Life Sciences, about opportunities in the Malaysian market.
February 17, 2015